Canada vs Malta: Proportion of isolates with decreased susceptibility or resistance
Canada
0.5445
in 2018
Malta
0
in 2018
Canada rank
13th
Malta rank
15th
Proportion of isolates with decreased susceptibility or resistance over time
- Canada
- Malta
How they compare
Canada currently reports 0.5445 against 0 in Malta, a difference of 0.5445.
The two have swapped places 2 times across 10 shared years of data; in 2009 it was Canada ahead.
Canada ranks 13th and Malta ranks 15th of 27 countries.
Canada has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Canada | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.13 | 0 | 1.13 | Canada |
| 2010s | 1.78 | 0.8547 | 0.9236 | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Canada or Malta?
- Canada, at 0.5445 against 0 in Malta as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Canada and Malta?
- 0.5445, with Canada ahead.
- How many years of comparable data are there for Canada and Malta?
- 10 years are reported by both, from 2009 to 2018.
- How do Canada and Malta rank globally for proportion of isolates with decreased susceptibility or resistance?
- Canada ranks 13th and Malta ranks 15th of 27 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.